Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional radiofrequency plus topical tretinoin for striae distensae
2021-003153-39Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of tretinoin in Striae atrophicae (SA), sponsored by Bispebjerg and Frederiksberg Hospital. Started Oct 2021; status: completed.
02
Drugs
tretinoin
03
Conditions
Striae atrophicae (SA)
Beyond the preview
Go deeper on 2021-003153-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003153-39.